Skip to main content

Table 1 The baseline characteristics of PCOS women grouped according to whether or not the intial rFSH dose were stepped up

From: Can AMH levels predict the need to step up FSH dose for controlled ovarian stimulation following a long GnRH agonist protocol in PCOS women?

 

ALL

(n = 825)

Did not step up rFSH dose

(n = 508)

Need to step up rFSH dose

(n = 317)

P Value

Age, y

30.2 ± 3.8

29.6 ± 3.5

29.9 ± 3.4

0.193

BMI, kg/m2

21.26 ± 2.98

21.1 ± 2.8

22.6 ± 3.4

0.002

Duration of infertility, y

4.0 ± 2.7

3.9 ± 2.3

4.1 ± 2.4

0.089

Infertility type, %

   

0.654

Primary

57.4% (473)

57.9% (294)

56.6% (179)

 

Secondary

42.6% (352)

42.1% (214)

43.4% (138)

 

Serum LH, IU/L

8.18 ± 5.40

8.00 ± 5.44

8.46 ± 5.32

0.237

Serum FSH, IU/L

6.90 ± 1.61

6.98 ± 1.62

6.78 ± 1.59

0.096

Serum T, ng/ml

0.55 ± 0.20

0.53 ± 0.20

0.58 ± 0.21

< 0.001

AFC

31.6 ± 9.9

31.0 ± 9.3

32.0 ± 10.8

0.03

Serum AMH, ng/mL

9.72 ± 3.45

8.69 ± 3.16

11.37 ± 3.25

< 0.001

Initial rFSH dose

112.5 (100, 150)

112.5 (100, 150)

112.5 (100, 150)

0.195

  1. LH: luteinizing hormone; FSH: follicle stimulation hormone; T: testosterone; BMI: body mass index; AFC: antral follicle count; AMH: anti-Mullerian hormone
  2. Data are presented as mean ± standard deviations, percentages (%) or median (25%, 75%). P value comparing two groups are determined with the t- test, the chi-squared test or the Mann-Whitney U test